Cronus Pharma draws PE interest four years after failed Aurobindo deal
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Cronus Pharma draws PE interest four years after failed Aurobindo deal

Cronus Pharma draws PE interest four years after failed Aurobindo deal

By Debjyoti Roy

  • 13 Aug 2025
Pro
Cronus Pharma draws PE interest four years after failed Aurobindo deal
Credit: Pexels

Cronus Pharma, an animal healthcare company that top Indian drugmaker Aurobindo Pharma wanted to acquire in 2021 before ......

New to VCCircle.com?

Subscribe to VCCircle PRO and get privileged access to exclusive curated articles!

Already a VCCircle PRO member? Click here to log in.
Advertisement

Related Articles

Pro
Creador stares at a tepid exit from nine-year-old healthcare portfolio firm

Healthcare

Creador stares at a tepid exit from nine-year-old healthcare portfolio firm

Kedaara-backed Neurealm acquires healthcare tech services firm Veersa

Healthcare

Kedaara-backed Neurealm acquires healthcare tech services firm Veersa

Pro
Kedaara's public markets fund adds Jhunjhunwala family-backed firm to portfolio

Healthcare

Kedaara's public markets fund adds Jhunjhunwala family-backed firm to portfolio

Premium
Nabventures-backed Avis Hospitals in talks to snag PE funding

Healthcare

Nabventures-backed Avis Hospitals in talks to snag PE funding

Premium
PE-backed drugmaker Brinton eyes fresh fundraise, hires banker

Healthcare

PE-backed drugmaker Brinton eyes fresh fundraise, hires banker

Premium
Tata 1mg hits the pedal on cluster-driven expansion

Healthcare

Tata 1mg hits the pedal on cluster-driven expansion

Premium
Health-tech startup Aurae eyes pre-Series A funding round

Healthcare

Health-tech startup Aurae eyes pre-Series A funding round

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW